Inhibition or knockdown of RSK1/2 strongly reduced EphA2-S897 phosphorylation in favor of the ligand-induced tumor-suppressive tyrosine phosphorylation, thus triggering downregulation of EphA2 and reverting platinum resistance of the ovarian cancer cells [140]. The gene discussed is EPHA2; the disease is neoplasm.